Respiratory Syncytial Virus in Older Adults: Setting the Foundation

Download All
In this series of concise Medical Minute videos with companion podcasts, commentaries, and a living downloadable slide set, hear experts discuss key strategies for evaluating the risk of severe outcomes due to RSV in older adults and the latest data from ongoing prevention research.
person default
Zhuxin Moa, PhD
Ting Shi, PhD
Dexter James Wiseman, MD

ClinicalThought

New reports from ECCMID 2022 shed light on the disease burden of RSV in older adults, as well as the impact of the COVID-19 pandemic on seasonal trends in RSV.

Ting Shi, PhD Released: May 19, 2022

There has never been a more promising time in the field of RSV for older adults than now, with the exciting preventive therapies on the horizon.

Dexter James Wiseman, MD Released: December 29, 2022

A new vaccine candidate for prevention of RSV in older adults was added to the EMA’s PRIME scheme. Here’s my summary of the key clinical trial information.

Ting Shi, PhD Released: August 18, 2022

Read my commentary on how RSV can have a detrimental impact on quality of life, especially in older adults.

person default Zhuxin Moa, PhD Released: January 30, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings